Kathleen Kirby

Company: Viridian Strategies

Job title: Principal

Seminars:

Panel Discussion: Addressing Challenges Associated with Viral Delivery Approaches 2:30 pm

Selecting the right delivery system to reduce unintended gene edits and increase accuracy Analyzing the benefits and drawbacks of using viral vectors for gene delivery Strategies for decreasing immune responses and enhancing the overall safety profile of gene-editing technologiesRead more

day: Day 2- translation 2

Panel Discussion: Breaking Boundaries: Navigating the Shift from Rare to Common Diseases in Gene Therapy 1:30 pm

• Exploring the unique challenges and benefits of expanding gene therapy into more prevalent conditions, including patient access, cost, and treatment scalability • Evaluating the feasibility of widespread gene therapy applications in common diseases by 2025, along with realistic goals and potential hurdles • Essential factors for successful translation, including regulatory preparedness, CMC adaptation, and…Read more

day: Focus Day

Roundtable: Overcoming the Challenges and & Maximizing Opportunities for Gene Therapy in Common Diseases 9:45 am

• Tackling the technical, regulatory, and financial barriers to gene therapy adoption in widespread conditions • Strategies to optimize manufacturing processes and reduce costs while maintaining efficacy and quality for larger populations • Identifying market access opportunities and pathways to ensure successful commercialization and patient accessRead more

day: Focus Day